Literature DB >> 15654834

T cell repertoire in patients with stable scleroderma.

K P Tiev1, J Abriol, M C Burland, D Antonelli, D Klatzmann, J Cabane, O Boyer.   

Abstract

At onset of systemic sclerosis (SSc), T cells have been found to oligoclonally expand in the skin, presumably in response to auto-antigens, but the T cell repertoire has not been evaluated at a later stage. To determine whether a perpetuating immune response contributes to the pathogenesis of stable SSc, the T cell repertoire was analysed in patients with diffuse (d) or limited (l) SSc, and compared to patients with primary Raynaud's phenomenon (RP) or healthy volunteers (Ctrl). The T cell repertoire (total, CD4 or CD8 sorted blood T cells) was analysed by qualitative and quantitative immunoscope (14 BV families analysed) in 11 untreated dSSc and 11 untreated lSSc, 10 RP and 11 Ctrl. To better detect in vivo activated cells, repertoire analysis was also performed on sorted CD4 T cells after in vitro culture with IL-2. In parallel, 6 skin biopsies from SSc patients were analysed. After 7-8 years of disease evolution, SSc patients did not show detectable clonal T cell expansions in the skin, even after tentative expansion from the biopsy with IL-2. Total T cell, sorted CD4 and CD8 T cell repertoires from the blood of patients with SSc did not show significant perturbation as compared to patients with RP and Ctrl. After IL-2 culture for 7 days, blood CD4 T cells from the patients did not preferentially expand as compared to RP and Ctrl. These findings suggest that antigen-driven immune responses may play a lesser role in established SSc than at disease onset.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654834      PMCID: PMC1809294          DOI: 10.1111/j.1365-2249.2004.02647.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Oligoclonal T cell expansion in the skin of patients with systemic sclerosis.

Authors:  Lazaros I Sakkas; Bin Xu; Carol M Artlett; Song Lu; Sergio A Jimenez; Chris D Platsoucas
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

2.  High expression and autoinduction of monocyte chemoattractant protein-1 in scleroderma fibroblasts.

Authors:  T Yamamoto; B Eckes; T Krieg
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

3.  Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis.

Authors:  T Yamamoto; B Eckes; K Hartmann; T Krieg
Journal:  J Dermatol Sci       Date:  2001-06       Impact factor: 4.563

Review 4.  Abnormalities of adhesion molecules and chemokines in scleroderma.

Authors:  S Sato
Journal:  Curr Opin Rheumatol       Date:  1999-11       Impact factor: 5.006

5.  Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis.

Authors:  J Nishio; M Suzuki; N Miyasaka; H Kohsaka
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

6.  Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients.

Authors:  O Benveniste; P Chérin; T Maisonobe; R Merat; O Chosidow; L Mouthon; L Guillevin; A Flahault; M C Burland; D Klatzmann; S Herson; O Boyer
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

7.  Increased levels of alternatively spliced interleukin 4 (IL-4delta2) transcripts in peripheral blood mononuclear cells from patients with systemic sclerosis.

Authors:  L I Sakkas; C Tourtellotte; S Berney; A R Myers; C D Platsoucas
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

8.  Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing-remitting MS.

Authors:  P A Muraro; L Bonanni; B Mazzanti; A Pantalone; E Traggiai; L Massacesi; M Vergelli; D Gambi
Journal:  J Neuroimmunol       Date:  2002-06       Impact factor: 3.478

9.  CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts.

Authors:  B Saitta; S Gaidarova; L Cicchillitti; S A Jimenez
Journal:  Arthritis Rheum       Date:  2000-10

10.  Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.

Authors:  Yasuji Mori; Shu-Jen Chen; John Varga
Journal:  Arthritis Rheum       Date:  2003-07
View more
  12 in total

Review 1.  T cells and B cells in the pathogenesis of systemic sclerosis: recent insights and therapeutic opportunities.

Authors:  Francesco Del Galdo; Carol M Artlett
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

2.  Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin.

Authors:  Raffaele De Palma; Francesco Del Galdo; Salvatore Lupoli; Paolo Altucci; Gianfranco Abbate; Gabriele Valentini
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

Review 3.  Interstitial lung disease in systemic sclerosis: current and future treatment.

Authors:  Roberto Giacomelli; Vasiliki Liakouli; Onorina Berardicurti; Piero Ruscitti; Paola Di Benedetto; Francesco Carubbi; Giuliana Guggino; Salvatore Di Bartolomeo; Francesco Ciccia; Giovanni Triolo; Paola Cipriani
Journal:  Rheumatol Int       Date:  2017-01-06       Impact factor: 2.631

4.  Subset-specific alterations in frequencies and functional signatures of γδ T cells in systemic sclerosis patients.

Authors:  Ana Henriques; Cláudia Silva; Mariana Santiago; Maria João Henriques; António Martinho; Hélder Trindade; José António Pereira da Silva; Bruno Silva-Santos; Artur Paiva
Journal:  Inflamm Res       Date:  2016-08-30       Impact factor: 4.575

Review 5.  Missing: a diagnostic technique to enumerate antigen-specific T cells.

Authors:  Melinda Shelley Suchard
Journal:  Crit Rev Oncol Hematol       Date:  2011-12-03       Impact factor: 6.312

6.  Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema.

Authors:  Andrew K Sullivan; Philip L Simonian; Michael T Falta; John D Mitchell; Gregory P Cosgrove; Kevin K Brown; Brian L Kotzin; Norbert F Voelkel; Andrew P Fontenot
Journal:  Am J Respir Crit Care Med       Date:  2005-06-03       Impact factor: 21.405

Review 7.  Current perspectives on the role of CD8+ T cells in systemic sclerosis.

Authors:  Patrizia Fuschiotti
Journal:  Immunol Lett       Date:  2017-10-05       Impact factor: 3.685

8.  Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy.

Authors:  Ankoor Shah; Jan Storek; Rob Woolson; Ashley Pinckney; Lynnette Keyes-Elstein; Paul K Wallace; Gregory D Sempowski; Peter McSweeney; Maureen D Mayes; Leslie Crofford; M E Csuka; Kristine Phillips; Dinesh Khanna; Robert Simms; Karen Ballen; Sharon LeClercq; William St Clair; Andrew B Nixon; Richard Nash; Mark Wener; Richard Brasington; Richard Silver; Linda M Griffith; Daniel E Furst; Ellen Goldmuntz; Keith M Sullivan
Journal:  Rheumatology (Oxford)       Date:  2022-10-06       Impact factor: 7.046

9.  A Paradigmatic Interplay between Human Cytomegalovirus and Host Immune System: Possible Involvement of Viral Antigen-Driven CD8+ T Cell Responses in Systemic Sclerosis.

Authors:  Maria-Cristina Arcangeletti; Clara Maccari; Rosanna Vescovini; Riccardo Volpi; Dilia Giuggioli; Gianluca Sighinolfi; Flora De Conto; Carlo Chezzi; Adriana Calderaro; Clodoveo Ferri
Journal:  Viruses       Date:  2018-09-18       Impact factor: 5.048

10.  Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease.

Authors:  José Manuel López-Cacho; Soledad Gallardo; Manuel Posada; Miriam Aguerri; David Calzada; Teodoro Mayayo; María Luisa González-Rodríguez; Antonio María Rabasco; Carlos Lahoz; Blanca Cárdaba
Journal:  Biomed Res Int       Date:  2014-04-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.